Recipharm has signed an agreement on the EQMS (Electronic Quality Management System) product FormPipe Life Science to streamline multiple quality and compliance processes. The total order value amounts to 2.5 million SEK to FormPipe Software.
Aptalis Pharmaceutical Technologies, formerly Eurand Pharmaceutical Technologies, today announced that the European Commission granted marketing authorization for a new pediatric indication of a new oral granule formulation of Gilead Sciences, Inc.'s Viread® (tenofovir disoproxil fumarate) for HIV-1 infected children aged 2 to less than 6 years, and for HIV-1 infected children above 6 years of age for whom a solid dosage form is not appropriate.
CROMSOURCE, an international full service contract research organization (CRO) today announced the appointment of Dr Christian Milla as Global Head of the Medical Division with immediate effect. Dr Milla will also take responsibility for CROMSOURCE operations in France as Country Manager.
CROMSOURCE, an international full service contract research organization (CRO) today announced the acquisition of PDR Partners Ltd, an established staffing and recruitment organization with offices in Bracknell, UK.
CROMSOURCE, an international full service contract research organisation (CRO) today announced the acquisition of Pleiad, an established international CRO with offices in the US (Cambridge, Mass.) and UK (Stirling, Scotland).
CROMSOURCE srl, an international full service contract research organisation (CRO) today announced the completion of an innovative private-public deal with Centro Ricerche Cliniche di Verona (CRC), a modern early phase clinical research unit, founded in 2005.
CROM acquires MSOURCE, a mid-size European Clinical Research Organisation (CRO) Specializing in Staffing Solutions and Medical Device Trials, creating CROMSOURCE.
Paperless Lab Forum 2013 Open for early bird registration. Paperless Lab Forum 2013 will be held on 17 & 18 April. Over 15 event sponsors and many life demos will provide you with the latest technology developments, practical conceptual approaches and customer presentations, to drive effective Paperless Lab initiatives.
QbD and Paperless Lab processes enables organizations to create start-to-finish knowledge management repository to adopt cross functional collaboration between management, scientists and engineers responsible for products in development and manufacturing, processes, equipment and facilities.
Dora Wirth Languages will be exhibiting at Genesis 2012 - London's premier Life Sciences & Healthcare networking conference - on Thursday 13th December 2012. Visitors are welcome to stand 66 to discuss their translation requirements.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.